U 3773 U 3773 (Ogen 1.25 1.5 mg)

Generic Name: estropipate

Pill imprint U 3773 U 3773 has been identified as Ogen 1.25 1.5 mg.

Ogen 1.25 is used in the treatment of osteoporosis; postmenopausal symptoms; primary ovarian failure; oophorectomy; atrophic vaginitis (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Ogen 1.25 1.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for U 3773 U 3773

Ogen 1.25 1.5 mg U 3773 U 3773 Front
Ogen 1.25 1.5 mg U 3773 U 3773 Back
Ogen 1.25 1.5 mg U 3773 U 3773
Ogen 1.25
Generic Name:
estropipate
Imprint:
U 3773
U 3773
Strength:
1.5 mg
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Estrogens
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC):
00009-3773
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-1261 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)